Estrella Immunopharma Announces Appointment of Hong Zhang as Chairperson and Board Member

Retrieved on: 2024-08-14 22:05:42

Tags for this article:

Click the tags to see associated articles and topics

Estrella Immunopharma Announces Appointment of Hong Zhang as Chairperson and Board Member. View article details on hiswai:

Summary

The article details Estrella Immunopharma's focus on biopharma, highlighting their CD19-targeted therapies for cancer and autoimmune diseases. It mentions key biomarkers (CD19, CD22) and the appointment of Hong Zhang as Chairperson, supporting their biopharma endeavors.

Article found on: www.placera.se

View Original Article